Thanks @NarjustFlorezMD and @Florez_Lab for the beautiful pin to raise awareness of lung cancer, especially in women. #hearher #LCSM

CNS-only progression for patient on 1L entrectenib for ROS1 disease. Likely too many for gamma knife. What would you do? #LCSM

Presentations by medical students/residents/fellows are the best. So exciting to have young colleagues share their perspective and enthusiasm. #ASCO2022

Tempting to say receipt of adjuvant chemo for early stage NSCLC is a med onc quality metric, however, we must acknowledge some of this is not necessarily modifiable. A lot of patients aren't enthused by 5% OS benefit, for PD-L1 neg, EGFR neg pt's. #LCSM

Congrats on great talk by @BrendanHeiden on developing operative quality score on early stage, N0, NSCLC. Might be most important talk I've heard so far, truly a #cancergroundshot #ASCO22 #LCSM. What would med onc and rad onc quality parameters look like...

Good panel on treatment sequencing for NSCLC. First time I have ever heard treatment deescalation for lung cancer. I know we have had some progress, but deescalation seems a bit premature, no? #ASCO22 #LCSM

So proud to work with @MVanMeterMD at @intermtncancer Great summary at @SUMOncology #ASCO21 update meeting on lingering questions from OlympiA trial.

Still waiting for @marklewismd to pull a Dwight Schrute at @SUMOncology

“With virtual meetings we don’t return to the office because we never left the office.” @marklewismd speaks truth at a fantastic in-person meeting in Salt Lake by @SUMOncology. Great to be in-person.

Grateful to be back at an in-person meeting and learning at the feet of my mentor ⁦@WAkerleyMD⁩ from ⁦@huntsmancancer⁩. Great update of progress in lung Ca. Thanks ⁦@SUMOncology⁩ for hosting this great event. #LCSM

I miss in-person meeting, but I really like the question format with voting and moderators to select the questions. Far superior to random questions at the microphone. Please @ASCO find a way to keep this. #ASCO21

I don't tweet often, but I want to highlight practice changing stuff. Presser on IMpower010 (adj atezo, St II-IIIA NSCLC post chemo) is potentially that. HR 0.66 for recurrence/death in PD-L1 expressing NSCLC. Can't wait to see more data. Congrats @HwakeleeMD. #LCSM #ASCO21

15min phone call w/ PBM for prior auth for selpercatinib that was denied. Questions are confusing to me, let alone my staff. Seems like they are designed to lead to denial. Love getting questions from "peer" who cannot pronounce hypocalcemia or hypomagnesemia. Sigh. #MedTwitter

Really,really great @NEJM commentary: https://t.co/9g782M8K8d. What can I always offer my patients: "giving someone the space to be known". Simple, but profound. Thx @LisaRosenbaum17 for your beautiful writing.

I lost my stethoscope the other day and came into my office to find this, from one of my sweetest patients. I am continually humbled and amazed by the generosity of my patients.

Anyone else a little blown away by this figure by @GoldmanLisa ? Just goes to show how important it is to hear the patient's voice as they see things very different. #WCLC20

For anyone else struggling to navigate #WCLC20 I found this overview at a glance helpful: https://t.co/9IEgE0r4xM. You can't select your exact time zone, but can at least get close. I like the 1-page overview to plan things out.

Really like this slide from a presentation this morning.

Anyone know if @christhile and @odonovanaoife Wassail live stream event on @mandolinlive will be available to watch after live event? Would love to watch, but not sure I can watch live. Details not clear on site.

"[The friend] has provided him w/ new sleeping bag and blankets. She will try to get the day off of his scheduled biopsy. She said she will put him up in a hotel the day of the biopsy so he has a warm place to stay after procedure." I am thankful for good, kind people. #LCSM 2/2